- $1.72bn
- $2.25bn
- $891.34m
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 230 | 306 | 502 | 701 | 891 |
Cost of Revenue | |||||
Gross Profit | 10.6 | -69.7 | -171 | -194 | -508 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 278 | 873 | 940 | 1,382 | 2,235 |
Operating Profit | -48.1 | -567 | -437 | -681 | -1,344 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -83.7 | -627 | -476 | -723 | -1,376 |
Provision for Income Taxes | |||||
Net Income After Taxes | -83.7 | -596 | -460 | -724 | -1,369 |
Net Income Before Extraordinary Items | |||||
Net Income | -83.7 | -596 | -460 | -724 | -1,369 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -85.6 | -596 | -460 | -724 | -1,369 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.359 | -0.969 | -0.812 | -1.24 | -2 |